Curosurf

Curosurf

Manufacturer:

Chiesi

Distributor:

Firma Chun Cheong
/
Zenfields
Concise Prescribing Info
Contents
Poractant alfa
Indications/Uses
Treatment of resp distress syndrome (RDS) in pre-term babies. Prophylactic use in premature infants at risk for RDS.
Dosage/Direction for Use
Rescue treatment 100-200 mg/kg (1.25-2.5 mL/kg) body wt, additional doses of 100 mg/kg each 1 at about 12 hrly intervals for infants still requiring assisted ventilation & supplementary oxygen. Prophylaxis Administer same dose w/in 15 min after birth, further doses of 100 mg/kg can be given 6-12 hr after the 1st dose then at 12 hrly intervals if necessary. Max total dose: 300-400 mg/kg. To be administered via intratracheal tube.
Special Precautions
Correction of acidosis, hypotension, anaemia, hypoglycaemia & hypothermia. Babies born following very prolonged rupture of the membranes (>3 wk) may not show optimal response.
Adverse Reactions
ATC Classification
R07AA02 - natural phospholipids ; Belongs to the class of lung surfactants. Used in the treatment of respiratory diseases.
Presentation/Packing
Form
Curosurf vial 240 mg/3 mL
Packing/Price
3 mL x 1's
Form
Curosurf vial 120 mg/1.5 mL
Packing/Price
1.5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in